WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for ProQR Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-09 3:31 pm Sale |
2022-04-29 | 13G | ProQR Therapeutics N.V. PRQR |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-4,017,760 (Position Closed) |
Filing |
| 2022-02-04 09:12 am Purchase |
2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
WELLINGTON MANAGEMENT CO LLP | 4,017,760 5.650% |
561,995 (+16.26%) |
Filing |
| 2021-02-03 1:22 pm Sale |
2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
WELLINGTON MANAGEMENT CO LLP | 3,455,765 6.390% |
-2,039,363 (-37.11%) |
Filing |